As the panel discussion concludes, expert panelists share their final insights about the current US healthcare system and its initiatives to combat cardiovascular disease and cardiometabolic events.
David Calabrese, RPh, MHP, explains that although challenges exist they are not “insurmountable.” He believes that in order to overcome the current treatment barriers, a patient-centric approach is necessary when caring for patients.
Kenneth L. Schaecher, MD, FACP, CPC, and Yehuda Handelsman, MD, FACP, FACE, FNLA, agree that medicine is at an exciting era in the US, as new innovations provide additional tools to help coordinate care between clinicians and their patients. However, Dr Handelsman reminds that the US needs to develop programs that help pay for the expensive costs of healthcare.
Michael Weber, MD, concludes the discussion by defining preventive medicine and explains its importance when managing cardiometabolic conditions.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
RFK Jr Claims HHS Has Not Fired Working Scientists, Canceled Lifesaving Research
May 15th 2025Robert F. Kennedy Jr’s congressional hearing featured numerous statements from the secretary of HHS, including denouncing claims of cutting down the HHS and the National Institutes of Health.
Read More
Trump Administration Walks Back Mental Health Parity in Insurance Coverage
May 13th 2025The Trump administration has decided to further debate the federal rule passed during the Biden administration that guaranteed insurance coverage for treatment of mental illness and substance abuse.
Read More